MoneyWorks4Me

NATCO Pharma informs about certificate

08 Apr 2022 Evaluate

NATCO Pharma has informed that it enclosed Certificate under Regulation 74{5) of the SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..